Report cover image

North America Tissue Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Disease Type (Breast Cancer, Lymphoma, Prostate Cancer, Gastric Cancer, Non-small Cell Lung Cancer, and Others), By End User, By Country and Growth

Publisher Knowledge Based Value (KBV) Research
Published Jan 31, 2024
Length 146 Pages
SKU # KBV18593062

Description

North America Tissue Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Disease Type (Breast Cancer, Lymphoma, Prostate Cancer, Gastric Cancer, Non-small Cell Lung Cancer, and Others), By End User, By Country and Growth Forecast, 2023 - 2030


The North America Tissue Diagnostics Market would witness market growth of 8.5% CAGR during the forecast period (2023-2030).

The era of personalized medicine has propelled the demand for tissue diagnostics, especially in oncology. Biomarker discovery and validation are central in tailoring treatment strategies to individual patients. It enables the identification of predictive and prognostic biomarkers, guiding the selection of targeted therapies and immunotherapies. Multimodal diagnostics, combining various diagnostic modalities such as imaging, genomics, and proteomics, is becoming increasingly prevalent. Integrating diverse data sets enhances the comprehensive characterization of diseases, providing a holistic understanding beyond traditional tissue morphology.

Furthermore, innovation is a driving force in the tissue diagnostics market, spurring the development of novel technologies and methodologies that redefine diagnostic capabilities. Immunohistochemistry, a cornerstone of tissue diagnostics, continues to see advancements in antibody specificity, staining techniques, and multiplexing capabilities. These developments enhance the precision and sensitivity of IHC, allowing for the simultaneous visualization of multiple biomarkers within the same tissue sample.

In accordance with the Centers for Medicare & Medicaid Services of the Government of the United States, spending on healthcare in the United States increased by 2.7 percent in 2021 to $4.3 trillion, or $12,914 per person. Spending on healthcare accounted for 18.3 percent of the country's GDP. Likewise, as per the data from Research America, United States (U.S.) medical and health research and development (R&D) investment reached $245.1 billion in 2020, an 11.1% increase from 2019.

The US market dominated the North America Tissue Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,929.9 million by 2030. The Canada market is showcasing a CAGR of 10.9% during (2023 - 2030). Additionally, The Mexico market would register a CAGR of 9.9% during (2023 - 2030).

Based on Product, the market is segmented into Consumables (Antibodies, Kits, Reagents, Probes), and Instruments (Slide-staining Systems, Scanners, Tissue Processing Systems, Others). Based on Technology, the market is segmented into Immunohistochemistry, In Situ Hybridization, Digital Pathology & Workflow, and Special Staining. Based on Disease Type, the market is segmented into Breast Cancer, Lymphoma, Prostate Cancer, Gastric Cancer, Non-small Cell Lung Cancer, and Others. Based on End User, the market is segmented into Hospitals, Research Laboratories, Pharmaceutical Organizations, Contract Research Organizations (CROs), and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • PHC Holdings Corporation
  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories
  • Merck KGaA
  • Sakura Finetek USA, Inc.
  • Abcam Plc
  • Amos scientific Pty Ltd.
  • Dakewe Biotech Co., Ltd.
North America Tissue Diagnostics Market Report Segmentation

By Product
  • Consumables
  • Instruments
By Technology
  • Immunohistochemistry
  • In Situ Hybridization
  • Digital Pathology & Workflow
  • Special Staining
By Disease Type
  • Breast Cancer
  • Lymphoma
  • Prostate Cancer
  • Gastric Cancer
  • Non-small Cell Lung Cancer
  • Others
By End User
  • Hospitals
  • Research Laboratories
  • Pharmaceutical Organizations
  • Contract Research Organizations (CROs)
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

146 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Tissue Diagnostics Market, by Product
1.4.2 North America Tissue Diagnostics Market, by Technology
1.4.3 North America Tissue Diagnostics Market, by Disease Type
1.4.4 North America Tissue Diagnostics Market, by End User
1.4.5 North America Tissue Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 Market Share Analysis, 2022
4.2 Porter Five Forces Analysis
Chapter 5. North America Tissue Diagnostics Market by Product
5.1 North America Consumables Market by Country
5.2 North America Tissue Diagnostics Market by Consumables Product
5.2.1 North America Antibodies Market by Country
5.2.2 North America Kits Market by Country
5.2.3 North America Reagents Market by Country
5.2.4 North America Probes Market by Country
5.3 North America Instruments Market by Country
5.4 North America Tissue Diagnostics Market by Instruments Product
5.4.1 North America Slide-staining Systems Market by Country
5.4.2 North America Scanners Market by Country
5.4.3 North America Tissue Processing Systems Market by Country
5.4.4 North America Others Market by Country
Chapter 6. North America Tissue Diagnostics Market by Technology
6.1 North America Immunohistochemistry Market by Country
6.2 North America In Situ Hybridization Market by Country
6.3 North America Digital Pathology & Workflow Market by Country
6.4 North America Special Staining Market by Country
Chapter 7. North America Tissue Diagnostics Market by Disease Type
7.1 North America Breast Cancer Market by Country
7.2 North America Lymphoma Market by Country
7.3 North America Prostate Cancer Market by Country
7.4 North America Gastric Cancer Market by Country
7.5 North America Non-small Cell Lung Cancer Market by Country
7.6 North America Others Market by Country
Chapter 8. North America Tissue Diagnostics Market by End User
8.1 North America Hospitals Market by Country
8.2 North America Research Laboratories Market by Country
8.3 North America Pharmaceutical Organizations Market by Country
8.4 North America Contract Research Organizations (CROs) Market by Country
8.5 North America Others Market by Country
Chapter 9. North America Tissue Diagnostics Market by Country
9.1 US Tissue Diagnostics Market
9.1.1 US Tissue Diagnostics Market by Product
9.1.1.1 US Tissue Diagnostics Market by Consumables Product
9.1.1.2 US Tissue Diagnostics Market by Instruments Product
9.1.2 US Tissue Diagnostics Market by Technology
9.1.3 US Tissue Diagnostics Market by Disease Type
9.1.4 US Tissue Diagnostics Market by End User
9.2 Canada Tissue Diagnostics Market
9.2.1 Canada Tissue Diagnostics Market by Product
9.2.1.1 Canada Tissue Diagnostics Market by Consumables Product
9.2.1.2 Canada Tissue Diagnostics Market by Instruments Product
9.2.2 Canada Tissue Diagnostics Market by Technology
9.2.3 Canada Tissue Diagnostics Market by Disease Type
9.2.4 Canada Tissue Diagnostics Market by End User
9.3 Mexico Tissue Diagnostics Market
9.3.1 Mexico Tissue Diagnostics Market by Product
9.3.1.1 Mexico Tissue Diagnostics Market by Consumables Product
9.3.1.2 Mexico Tissue Diagnostics Market by Instruments Product
9.3.2 Mexico Tissue Diagnostics Market by Technology
9.3.3 Mexico Tissue Diagnostics Market by Disease Type
9.3.4 Mexico Tissue Diagnostics Market by End User
9.4 Rest of North America Tissue Diagnostics Market
9.4.1 Rest of North America Tissue Diagnostics Market by Product
9.4.1.1 Rest of North America Tissue Diagnostics Market by Consumables Product
9.4.1.2 Rest of North America Tissue Diagnostics Market by Instruments Product
9.4.2 Rest of North America Tissue Diagnostics Market by Technology
9.4.3 Rest of North America Tissue Diagnostics Market by Disease Type
9.4.4 Rest of North America Tissue Diagnostics Market by End User
Chapter 10. Company Profiles
10.1 F. Hoffmann-La Roche Ltd.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.6 SWOT Analysis
10.2 Danaher Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 SWOT Analysis
10.3 PHC Holdings Corporation
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental Analysis
10.3.4 Recent strategies and developments:
10.3.4.1 Partnerships, Collaborations, and Agreements:
10.3.5 SWOT Analysis
10.4 Thermo Fisher Scientific, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.6 SWOT Analysis
10.5 Abbott Laboratories
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 SWOT Analysis
10.6 Merck KGaA
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.6.6 SWOT Analysis
10.7 Sakura Finetek USA, Inc.
10.7.1 Company Overview
10.7.2 SWOT Analysis
10.8 Abcam Plc
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 SWOT Analysis
10.9 Amos scientific Pty Ltd.
10.9.1 Company Overview
10.9.2 SWOT Analysis
10.10. Dakewe Biotech Co., Ltd.
10.10.1 Company Overview
10.10.2 SWOT Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us